ghk-cu declines with age Cooper Peptide: The Complete Skin & Repair Guide (2026) GHK-Cu Copper Peptide for Anti-Aging
Description
Noah Leibold, James R
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis (ALS), or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin
INVIMA has not approved it for therapeutic use
Nearly all of the evidence behind it comes from animal and in-vitro (preclinical) studies , not from completed human efficacy trials
